Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.
暂无分享,去创建一个
D. Stewart | M. Yanagisawa | T. Masaki | S. Kimura | R. Michel | R. Levy | H. Shennib | D. Langleben | S. Kimura | T Masaki | A Giaid | W. Duguid | M Yanagisawa | D Langleben | R P Michel | R Levy | H Shennib | S Kimura | W P Duguid | D J Stewart | A. Giaid | Tomoh Masaki | D. Stewart | M. Yanagisawa | William P. Duguid | Hani Shennib | William P. Duguid
[1] Sadao Kimura,et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.
[2] G. Dubyak,et al. Endothelin stimulates phospholipase C, Na+/H+ exchange, c-fos expression, and mitogenesis in rat mesangial cells. , 1989, The Journal of clinical investigation.
[3] E H Bergofsky,et al. Primary pulmonary hypertension. A national prospective study. , 1987, Annals of internal medicine.
[4] B. Magun,et al. Stimulation of phosphatidylinositol hydrolysis, diacylglycerol release, and gene expression in response to endothelin, a potent new agonist for fibroblasts and smooth muscle cells. , 1989, The Journal of biological chemistry.
[5] J. Vane,et al. The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes. , 1991, Biochemical and biophysical research communications.
[6] R. Furchgott,et al. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.
[7] I. Kanazawa,et al. Presence of endothelin-1 in porcine spinal cord: isolation and sequence determination. , 1989, Biochemical and biophysical research communications.
[8] S. Hsu,et al. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[9] M. Yanagisawa,et al. Elevated plasma levels of endothelin-1 in systemic sclerosis. , 1991, Arthritis and rheumatism.
[10] M. Yanagisawa,et al. A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. , 1989, The Journal of biological chemistry.
[11] R. Anderson,et al. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages , 1990, The Journal of experimental medicine.
[12] J. Vane,et al. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. , 1978, Pharmacological reviews.
[13] P. Vanhoutte,et al. Endothelium‐derived relaxing and contracting factors , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] M. Roncalli,et al. Distribution of endothelin-like immunoreactivity and mRNA in the developing and adult human lung. , 1991, American journal of respiratory cell and molecular biology.
[15] E. Weber,et al. Inducibleendothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells , 1990 .
[16] M. Kahaleh,et al. Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. Enhanced production and profibrotic action. , 1991, Arthritis and rheumatism.
[17] T. Krieg,et al. Localization of collagen mRNA in normal and scleroderma skin by in‐situ hybridization , 1988, European journal of clinical investigation.
[18] J. Edwards,et al. The Pathology of Hypertensive Pulmonary Vascular Disease: A Description of Six Grades of Structural Changes in the Pulmonary Arteries with Special Reference to Congenital Cardiac Septal Defects , 1958, Circulation.
[19] M. Porta,et al. Production of endothelin by vascular smooth muscle cells. , 1991, Journal of cardiovascular pharmacology.
[20] P. Wood. PULMONARY HYPERTENSION WITH SPECIAL REFERENCE TO THE VASOCONSTRICTIVE FACTOR* , 1958, British heart journal.
[21] J. Vane,et al. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[22] A. Lerman,et al. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. , 1991, The New England journal of medicine.
[23] C. Wagenvoort. Grading of pulmonary vascular lesions‐a reappraisal , 1981, Histopathology.
[24] R. Michel,et al. Increased resistance in postobstructive pulmonary vasculopathy: structure-function relationships. , 1991, Journal of applied physiology.
[25] M. Lewis,et al. Endothelium-derived relaxing factor. , 1988, Journal of the American College of Cardiology.
[26] Y. Hirata,et al. Endothelin is a potent mitogen for rat vascular smooth muscle cells. , 1989, Atherosclerosis.
[27] D. Stewart,et al. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? , 1991, Annals of internal medicine.
[28] G. Church,et al. Genomic sequencing. , 1993, Methods in molecular biology.
[29] Y. Yazaki,et al. Endothelin stimulates c‐fos and c‐myc expression and proliferation of vascular smooth muscle cells , 1988, FEBS letters.